# The Use of Laparoscopic Transversus Abdominis Plane Block in Gastric Bypass Surgery (LapTAP)

> **NCT03367728** · PHASE4 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 150 (estimated)

## Conditions studied

- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03367728
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-27
- **Primary completion:** 2020-02
- **Final completion:** 2020-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367728, "The Use of Laparoscopic Transversus Abdominis Plane Block in Gastric Bypass Surgery (LapTAP)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03367728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*